Viking Therapeutics (VKTX) Change in Acquisitions & Divestments (2015 - 2026)
Viking Therapeutics' (VKTX) quarterly Change in Acquisitions & Divestments came in at $141.0 million in Q2 2026, down 15.04% year-over-year from $166.0 million in Q2 2025, and up 11.37% quarter-over-quarter from $126.6 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Change in Acquisitions & Divestments across 12 years of filings, most recently posting $141.0 million for Q2 2026.
- In Q2 2026, Change in Acquisitions & Divestments fell 15.04% year-over-year to $141.0 million; the TTM figure through Jun 2026 stood at $565.2 million (down 27.65% YoY), while the FY2025 annual figure was $759.4 million, up 35.61% from the prior year.
- Change in Acquisitions & Divestments came in at $141.0 million for Q2 2026 at Viking Therapeutics, up from $126.6 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $295.9 million in Q1 2025 to a low of $32.3 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $114.6 million, with a median of $121.4 million recorded in 2025.
- Year-over-year, Change in Acquisitions & Divestments surged 163.05% in 2024 and sank 57.2% in 2026.
- Over 5 years, Change in Acquisitions & Divestments stood at $51.9 million in 2022, then jumped by 156.94% to $133.3 million in 2023, then climbed by 7.71% to $143.5 million in 2024, then decreased by 19.12% to $116.1 million in 2025, then increased by 21.46% to $141.0 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $141.0 million in Q2 2026, $126.6 million in Q1 2026, and $116.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.02 Mn |
| Mar 31, 2026 | 126.63 Mn |
| Dec 31, 2025 | 116.11 Mn |
| Sep 30, 2025 | 181.48 Mn |
| Jun 30, 2025 | 165.98 Mn |
| Mar 31, 2025 | 295.86 Mn |
| Dec 31, 2024 | 143.54 Mn |
| Sep 30, 2024 | 175.89 Mn |
| Jun 30, 2024 | 103.76 Mn |
| Mar 31, 2024 | 136.81 Mn |
| Dec 31, 2023 | 133.27 Mn |
| Sep 30, 2023 | 66.87 Mn |
| Jun 30, 2023 | 39.49 Mn |
| Mar 31, 2023 | 59.59 Mn |
| Dec 31, 2022 | 51.87 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jun 30, 2022 | 54.68 Mn |
| Mar 31, 2022 | 32.30 Mn |
| Dec 31, 2021 | 62.98 Mn |
| Sep 30, 2021 | 37.78 Mn |
API Access
Viking Therapeutics Change in Acquisitions & Divestments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-acquisitions-and-divestments", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();